This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kemp, C. J. Articles by Gurley, K. E. Search for Related Content PubMed PubMed Citation Articles by Kemp, C. J. Articles by Gurley, K. E.

p53 Induction and Apoptosis in Response to Radio- and Chemotherapy in Vivo Is Tumor-Type-dependent¹

Fred Hutchinson Cancer Research Center, Seattle, Washington 90109-1024

The p53 protein rapidly accumulates in cells in response to DNA damage, which can trigger apoptosis. This pathway is hypothesized to be important for tumor suppression by p53, as well as for the response of tumors to chemo- or radiotherapy. Implicit in these ideas is that the p53 induction-apoptosis pathway is active in tumor cells in vivo. Because tumor suppression by p53 in mice is markedly tissue-type-dependent, we tested the activity of the pathway in tumors in vivo by inducing tumors in six different tissues and treating tumor-bearing mice with DNA damaging cancer therapeutic agents. In response to treatment, cells from T-cell lymphomas, intestinal adenomas, and mammary tumors rapidly induced p53 and underwent apoptosis. In squamous cell papillomas, p53 was constitutively expressed and was further induced by the treatments, but apoptotic cells were only rarely observed. In treated mice bearing lung or liver adenomas, minimal or no p53 accumulation or apoptosis was observed in the tumor cells. Thus, there is marked variation in the intrinsic ability of autochthonous tumor cells to accumulate p53 and undergo apoptosis. This variation provides one explanation for the tissue specificity of tumor suppression by p53. It also indicates that the role of apoptosis in the response of tumors to therapy varies significantly among tumor types.

This article has been cited by other articles:

				R. M. Mroz, R. P. F. Schins, H. Li, L. A. Jimenez, E. M. Drost, A. Holownia, W. MacNee, and K. Donaldson Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways Eur. Respir. J., February 1, 2008; 31(2): 241 - 251. [Abstract] [Full Text] [PDF]

				K. E. Gurley and C. J. Kemp Ataxia-Telangiectasia Mutated Is Not Required for p53 Induction and Apoptosis in Irradiated Epithelial Tissues Mol. Cancer Res., December 1, 2007; 5(12): 1312 - 1318. [Abstract] [Full Text] [PDF]

				Y. Sun, Y. Mochizuki, and P. W. Majerus Inositol 1,3,4-Trisphosphate 5/6-Kinase Inhibits Tumor Necrosis Factor-induced Apoptosis J. Biol. Chem., October 31, 2003; 278(44): 43645 - 43653. [Abstract] [Full Text] [PDF]

				L. Ji, M. Nishizaki, B. Gao, D. Burbee, M. Kondo, C. Kamibayashi, K. Xu, N. Yen, E. N. Atkinson, B. Fang, et al. Expression of Several Genes in the Human Chromosome 3p21.3 Homozygous Deletion Region by an Adenovirus Vector Results in Tumor Suppressor Activities in Vitro and in Vivo Cancer Res., May 1, 2002; 62(9): 2715 - 2720. [Abstract] [Full Text] [PDF]

				A. W. Lin and S. W. Lowe Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation PNAS, April 12, 2001; (2001) 91100298. [Abstract] [Full Text]

				A. W. Lin and S. W. Lowe Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation PNAS, April 24, 2001; 98(9): 5025 - 5030. [Abstract] [Full Text] [PDF]